NOTE: Please grab your lunch and be seated no later than 8:00 AM.

Please join us for a sponsored breakfast presentation by Otsuka, US!

This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics.